Reneo Pharmaceuticals
RPHM
$1.60
Share price
-0.31%
Change (1 day)
-76.57%
Change (1 year)
Categories
Reneo Pharmaceuticals (RPHM) - P/B ratio
P/B ratio as of June 2024 : 0.6623
According to Reneo Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 0.6623.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Reneo Pharmaceuticals - P/B ratio (from 2021 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 0.6015 | 5.21% |
| 2022-12-31 | 0.5717 | -59.7% |
| 2021-12-31 | 1.42 | |
| 2020-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 1.38 | 108.77% | 🇺🇸 USA |